UC2288 is a potent and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 potently inhibits cancer cell growth by inducing apoptosis. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 µM[1].
Molecular Weight:
481.82
Purity:
99.82
CAS Number:
[1394011-91-6]
Formula:
C20H18ClF6N3O2
Target:
Apoptosis,MDM-2/p53
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
